<DOC>
	<DOCNO>NCT01519804</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , placebo-controlled study evaluate efficacy safety onartuzumab ( MetMAb ) combination paclitaxel plus platinum patient incurable Stage IIIB Stage IV squamous non-small cell lung cancer ( NSCLC ) . Patients randomize receive either onartuzumab ( MetMAb ) 15 mg/kg iv placebo Day 1 21-day cycle combination 4 cycle paclitaxel 200 mg/m2 iv platinum ( carboplatin/cisplatin ) iv Day 1 21-day cycle . Patients progress 4 cycle continue either onartuzumab ( MetMAb ) placebo maintenance therapy disease progression unacceptable toxicity occur .</brief_summary>
	<brief_title>A Study Onartuzumab ( MetMAb ) Versus Placebo Combination With Paclitaxel Plus Platinum Patients With Squamous Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Histologically cytologically confirm Stage III B Stage IV squamous nonsmall cell lung cancer ( NSCLC ) Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 No prior chemotherapy squamous NSCLC Adequate tissue central IHC assay Met receptor , EGFR test EGFR status unknown Radiographic evidence disease Prior systemic treatment Stage IIIB IV squamous NSCLC NSCLC histology classify adenocarcinoma , large cell , mixed adenosquamous , NSCLC otherwise specify ( NOS ) Prior exposure experimental treatment target either HGF Met pathway Patients tumor confirm EGFRactivating mutation suitable antiEGFR therapy ( e.g . gefitinib erlotinib ) , determine investigator Uncontrolled brain metastasis treatment neurosurgical resection brain biopsy within 4 week prior Day 1 Cycle 1 History another malignancy previous 3 year except prior history situ cancer basal squamous cell skin cancer Pregnant lactate woman Uncontrolled diabetes Impaired bone marrow , liver renal function define protocol Significant history cardiovascular disease Positive HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>